Federal Supply Schedule 36F79724D017E
Award Date
1/16/24
Last Date to Order
7/14/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Adma Biologics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Adma Biologics, Inc., a for-profit pharmaceutical company, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12). The contract, valued up to $1,549,720, is for the provision of drugs, pharmaceuticals, and hematology-related products, with a period of performance through July 14, 2029. Additionally, Adma Biologics was awarded a $49,000,000 Blanket Purchase Agreement (BPA) by the National Acquisition Center, a...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Adma Biologics, Inc., a for-profit pharmaceutical company. The BPA has a ceiling value of $49,000,000 and runs through July 31, 2026. It covers the procurement of two plasma-derived pharmaceutical products: ASCENIV and BIVIGAM. Adma Biologics, which specializes in hematology-related products, also holds two Federal Supply Schedule (FSS) contracts with the Department of Veterans...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., provides access to critical pharmaceutical products and drugs to support the VA's healthcare programs for veterans. The master contract has a ceiling value of $201,482,280 and an ultimate completion date of September 29, 2026. Under this FSS-61-IB contract for Pharmaceuticals and Drugs, CSL Behring, a global biotherapeutics company, delivers specialty treatments such as...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 to Hema Biologics LLC, a for-profit limited liability company. The contract is for the procurement of pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a ceiling value of $225,000 and a period of performance through September 14, 2026. The contracted products and services encompass a broad range of drugs, pharmaceuticals, and...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The Department of Veterans Affairs (VA) has awarded Amivas US LLC a five-year, $225,000 multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This IDV allows VA medical facilities to issue task orders for Amivas' pharmaceuticals and hematology-related products. Amivas, a for-profit limited liability company, has prior experience providing pharmaceuticals and services related to clinical trials and medical research for federal agencies....
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
This is a multiple award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Invivyd, Inc. for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through November 14, 2024. As a Federal Supply Schedule contract, this agreement provides a streamlined procurement vehicle for federal agencies to acquire the covered pharmaceutical and...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
The Federal Supply Schedule (FSS) contract awarded to Organon LLC by the Department of Veterans Affairs (VA) National Acquisition Center provides a $1.5 million ceiling for the delivery of drugs, pharmaceuticals, and hematology-related products to various federal agencies, including the VA, Defense Health Agency, Bureau of Prisons, and Indian Health Service. This multiple-award FSS contract, which does not utilize any set-asides, covers a period of performance from January 15, 2022 to July 14,...